Table 3.
Study group | T, ng/dl | uT, ng/dl | DHEAS, ng/ml | LH, millunits/ml | FSH, millunits/ml |
---|---|---|---|---|---|
PCOS probands | 81 ± 40 (80)¶‖ | 30 ± 26 (79)† | 2,550 ± 1370 (80)¶‖ | 15 ± 10‖ (70) | 10 ± 4 (70) |
PCOS sisters | 82 ± 27 (17)¶‖ | 26 ± 11 (16)¶‖ | 2,600 ± 1360 (17)‖ | 13 ± 8 (15)‖ | 10 ± 3 (15) |
HA sisters | 86 ± 46 (19)¶‖ | 23 ± 10 (19)¶‖ | 2,990 ± 1520 (19)¶‖ | 34 ± 47 (14)†‡§¶‖ | 9 ± 4 (14) |
UA sisters | 32 ± 12 (43) | 6 ± 2 (43) | 1,610 ± 720 (43) | 8 ± 9 (36) | 11 ± 4 (36) |
Control subjects | 32 ± 12 (70) | 9 ± 6 (70) | 1,650 ± 730 (70) | 5 ± 4 (67) | 10 ± 4 (67) |
ANOVA, P value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.40 |
All values are given as mean ±SD (n). Significant values obtained with Scheffe’s post hoc test are noted:
, vs. PCOS probands;
, vs. PCOS sisters;
, vs. HA sisters;
, vs. UA sisters;
, vs. control subjects.